Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

A industry story from the U.S., reported by CNBC Top News.

Industry · the U.S. · October 13, 2026

From CNBC Top News

Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.

Reported by CNBC Top News, October 13, 2026. Read the full story at CNBC Top News →

More industry from the U.S.

All industry → · the U.S. local news →

Open HeyHomees →